期刊文献+

艾司西酞普兰与帕罗西汀治疗惊恐障碍对照研究 被引量:7

Study of escitalopram and paroxetine in treatment of panic disorder
在线阅读 下载PDF
导出
摘要 目的:研究艾司西酞普兰和帕罗西汀治疗惊恐障碍的有效性和安全性。方法:55例惊恐障碍患者随机分入艾司西酞普兰组与帕罗西汀组治疗10周,在治疗前和治疗期间隔周测定惊恐症状评定量表(PASS)、汉密尔顿焦虑量表(HAMA)及每周发作次数,以治疗中出现的症状量表(TESS)评定不良反应。结果:艾司西酞普兰组有效率为96.2%,帕罗西汀组为92.3%,二药相近。两组患者在治疗10周PASS、HAMA的减分率差异无显著性。艾司西酞普兰组的起效时间快于帕罗西汀组,差异具有显著性(P<0.01)。两组患者均有良好的耐受性。结论:艾司西酞普兰是一种起效快、疗效好、安全性高的治疗惊恐障碍的药物。 Objective:To evaluate the efficacy and safety of escitalopram and paroxetine in the treatment of patients with panic disorder.Methods:Fifty-five patients with panic disorder were randomly assigned to escitalopram group or sertraline group for 10 weeks.The panic symptom scale(PASS),Hamilton anxiety scale(HAMA) were used to evaluate the efficacy,and the treatment emergent symptom scale(TESS) were used to evaluate the side effects.Results: After 10 weeks treatment,the mean scores of PASS,HAMA reduced in both groups.The rates of efficacy of escitalopram and paroxetine were 96.2% and 92.3% respectively,and there were no statistically significant differences in the efficacy between two groups.But it took effect more quickly in escitalopram group than in paroxetine group(P0.01).Patients of both groups had good tolerance.Conclusions: Escitalopram is an effective and well-tolerated drug in the treatment of panic disorder,and takes effect quickly.
出处 《中国民康医学》 2012年第3期302-303,共2页 Medical Journal of Chinese People’s Health
关键词 艾司西酞普兰 帕罗西汀 惊恐障碍 Escitalopram Paroxetine Panic disorder
  • 相关文献

参考文献7

  • 1OWENS M J, Knight DL,Nemeroff CB, Second - generation SSRIs : human monoamine tr4ansporter binding profile of escitalopram and Rfluoxetine[ J]. Biol Psychiatry ,2001,50:345 - 350.
  • 2Sanchez C r - citalopram attenuates anxiolytic effects of escitalo- pram in a rat ultrasonic vocalization model [ J ]. Eur J Pharmcol, 2003. 464 : 155 - 158.
  • 3Michael G, Richhard M, Philip C, Short oxford Textbook of P sychi- atry[ M]. 5th ed , New Yord : Oxford University Press ,2006 : 193.
  • 4Stahl SM. Independent aetins on fear circuits may lead to therapeu- tic synergy for anxiety when combining serotonergie and GABAergic agents[ BRAINSTORMS]. J Clin Psychiatry ,2002,63:854 -855.
  • 5Kasper S,Resinger E. Panic disorder:the place of benzodiazepines and selective serotonin reuptake inhibitors [ J ]. Eur Neuropsycho- pharmacol,2001,11:307 - 321.
  • 6Sanchez C, Bergqvist PB, Brennum LT , et al. Escitalopram, the S ( + ) - enantiomer of citalopram, is a selective semtonin reuptake in hibitor with potent effects in animal models predictive of anti- depres - sam and anxiolytic activeties [ J ]. Psychopharmacology (Bed) ,2003,167:353 - 362.
  • 7Jonathan RT,Anjand B,Andrew K,et al,Escitalopram in the treat -ment of generalized anxiety disorder; double - blind , placebo - controlled, flexible - dose study[ J ]. Depression and anxiety, 2004, 19:234 - 240.

同被引文献55

  • 1余常红,胡赤怡,杨海晨,胡纪泽.惊恐障碍患者患病行为研究[J].中国行为医学科学,2005,14(7):616-617. 被引量:6
  • 2杨海晨,高欢,余常红.西酞普兰治疗惊恐障碍对照研究[J].山东精神医学,2006,19(3):186-187. 被引量:4
  • 3沈渔邮.精神病学[M].第4版.北京:人民卫生出版社,2006:460.
  • 4中华医学会精神科分会.中国精神障碍分类与诊断标准(第三版)[M].济南:山东科学技术出版社,2001.75-8.
  • 5刘力,李晓白,秦晓霞,毕红希.文拉法辛缓释剂和帕罗西汀治疗惊恐障碍的随机对照研究[J].中国新药与临床杂志,2007,26(10):768-771. 被引量:4
  • 6Kessler RC, Frank RG. The impact of psychiatric disorders on working lossdays [ J ]. Psycho/, 1997, 27 (4) :861 - 873.
  • 7Andersch S,Rosenberg NK,Kullingsjo H,et al. Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder, A Scandinavian muhicenter study [ J ]. Acta Psychiatr Scand, 1991, 83 ($365) :18 -27.
  • 8Argylb N, Dehito J, Allerup P, et al. The Panic - Associated Symp- tom Scale Measuring the severity of panic disorder[ J]. Acta Psy- chiatr Scand, 1991,83 ( I ) :20 - 26.
  • 9Baldwin DS, Anderson IM, Nutt D J, et al. Evidence - based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology [J]. J Psychopharmacol, 2005,19 (6) :567 - 596.
  • 10Culpepper I,. Identifying and treating panic disorder in primary care[J]. Clin Psychiatry, 2004,65 (Suppl 5 ) : 19 - 23.

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部